Applied Clinical Trials-07-01-2011

CRO/SPONSOR : Personalized Medicine Development - Role of CROs TRIAL DESIGN : Eye Movements Help Determine Side Effect Profiles SUBJECT RECRUITMENT : Connecting Type 2 Diabetics to Clinical Trials INFORMATION TECHNOLOGY : Cloud Computing Brings Efficiencies to Life Sciences Also in this issue : Biosimilars Development, Funding in Europe, Transforming R&D, Subject Protection in India

The disconnect coordinating and connecting interested patients to clinical trials is an ongoing struggle.

Two unique techniques help characterize pharmacodynamic drug effects in healthy subjects.

A newly released report has the pharma industry facing some new rivals.

What cloud computing is, why it can save time and money, and how to select the right cloud solution.

Our book review for the latest industry guidebook for monitors.

As the popularity of personalized medicine grows the role of the CRO continues to evolve.

Guido Rasi, MD, prepares to take on his new role.

Industry Standard Research has recently released its 3rd annual "CRO Quality Benchmarking Report." The report not only profiles the delivery quality of leading CROs, but also provides a wealth of information that relates to larger industry trends, including the value of recruitment speed.

Collaborative communities may hold the key to transforming a half-century's old R&D paradigm.

Debate narrows over extent of pre-clinical and clinical testing for follow-on versions of complex biologics.

Potential patients entering any trial need to be informed citizens able to understand and assert their rights.

Industry news focusing on the people and organizations who work in the clinical trials profession.